Orkla Asa Stock Earnings Reports

Orkla reported a solid Q1 with organic growth of 4.9% and underlying EBIT adjusted growth of 3%. Adjusted EPS rose 4% to NOK 1.75. Positive contributors were Jotun (strong operational performance), Orkla Snacks, Orkla Food Ingredients and Orkla Food, while Orkla Health weighed on consolidated results. Management highlighted volume/mix growth (Q1 volume/mix +2.2%) and continued commercial improvements, with modest seasonal uplift from Easter. Orkla repurchased NOK 1 billion of shares in Q1, ended the quarter with net debt of NOK 13.6 billion (approx. 1x EBITDA), and completed a bolt‑on acquisition for Food Ingredients. Jotun flagged substantial input‑cost pressure from Q2 (energy, freight, oil‑linked raw materials) and expects mitigation via price increases, alternative sourcing and cost control, but uncertainty remains given the Middle East conflict. Orkla Health delivered weak volumes, margin pressure and announced closure of three factories (gradual through end‑2026), making 2026 a challenging year for that segment. Management said they do not expect inflationary effects on the scale of the post‑pandemic period, but cost pressure (energy, freight, packaging) will materialize gradually through the year. The company remains focused on organic value creation, complexity reduction and maintaining balance‑sheet flexibility to pursue value‑accretive opportunities.